节点文献

BML-111通过抑制p38 MAPK/NF-κB通路减轻大鼠肠缺血再灌注早期急性肺损伤

BML-111 attenuats acute lung injury induced by intestine ischemia-reperfusion via inhibiting p38 MAPK/NF-kB signaling pathway

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 韩雪胡楚文罗慧姚伟锋周少丽罗雀华葛缅沈宁

【Author】 HAN Xue;HU Chu-wen;LUO Hui;YAO Wei-feng;ZHOU Shao-li;LUO Que-hua;GE Mian;SHEN Ning;Department of Anesthesiology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University;

【机构】 中山大学孙逸仙纪念医院中山大学附属第三医院广东省第二人民医院

【摘要】 目的:探讨脂氧素受体激动剂BML-111在肠缺血再灌注早期急性肺损伤中的作用及其机制。方法:32只8周龄健康雄性SD大鼠随机分为假手术组、缺血再灌注组、缺血再灌注+BML-111处理组(BML-111组)和缺血再灌注+Boc-2+BML-111处理组(Boc-2组),BML-111组和Boc-2组在再灌注开始时通过腹腔注射给予BML-111(1mg/kg),Boc-2组在麻醉后通过腹腔注射给予Boc-2(50μg/kg),另两组注入等量生理盐水。采用夹闭SD大鼠肠系膜上动脉45 min后再灌注6 h的方法造成肠缺血再灌注损伤模型。处死大鼠取肺标本,HE染色观察肺组织病理学改变,检测肺组织含水率;ELISA检测肺组织TNF-α、IL-1β和IL-6水平;蛋白质印迹法检测肺组织磷酸化p38 MAPK和NF-κB蛋白表达水平。结果 :肠缺血再灌注导致明显肺损伤,肺含水率增加,TNF-α、IL-1β和IL-6含量明显升高,p38 MAPK/NF-κB通路活化;BML-111可抑制肺组织p38 MAPK/NF-κB活化,减轻小肠缺血再灌注引起的肺损伤,并下调肺组织TNF-α、IL-1β和IL-6含量,当应用Boc-2处理后,BML-111的肺保护作用被取消。结论 :BML-111通过抑制p38 MAPK/NF-κB通路活化促进肠缺血再灌注早期肺损伤炎症消退。

【Abstract】 Objective This study aims to investigate the effect of Lipoxin A4 receptor on acute lung injury(ALI) induced by intestine ischemia-reperfusion(ⅡR).Methods Thirty-two 8-week old SD rats were randomly divided into four groups:sham,intestine ischemia-reperfusion(ⅡR),ⅡR + BML111(BML-111),Boc-2 + ⅡR +BML111(Boc-2).BML-111(1 mg/kg) was given intraperitoneally at the onset of reperfusion in the BML-111 and the Boc-2 group.Boc-2(50 μg/kg) was given intraperitoneally after anesthesia in the Boc-2 group.Rats were subjected to superior mesenteric artery occlusion consisting of 45-min ischemia and 6-h reperfusion,and the sham laparotomy was served as controls.The lung pathology was assayed by the H&E staining.Lung water content was detected using dry/wet ratio.Concentrations of TNF-α,IL-1β,and IL-6 in lung tissue were determined by ELISA.The protein expression of p38 MAPK and NF-kB of lung was assayed by western blot.Results ⅡR induced serious ALI,with poor lung pathology and increased lung water content,elevation of TNF-α,IL-1β,and IL-6 levels in lung,accompanied with activation of p38 MAPK/NF-κB pathway.However,BML-111 could inhibit the activation of p38 MAPK/NF-κB pathway,leading to the reductions of TNF-α,IL-1β,and IL-6 in lung and attenuation ofⅡR-induced ALI.Conclusion BML-111 treatment could attenuate inflammation in lung after ⅡR injury via inactivating the p38 MAPK/NF-κB signaling pathway.

【基金】 广东省科技计划项目(编号:2011B031800061)
  • 【文献出处】 实用医学杂志 ,The Journal of Practical Medicine , 编辑部邮箱 ,2016年19期
  • 【分类号】R574;R563
  • 【被引频次】8
  • 【下载频次】370
节点文献中: 

本文链接的文献网络图示:

本文的引文网络